Ensign Peak Advisors, Inc Incyte Corp Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Incyte Corp stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 310,648 shares of INCY stock, worth $23 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

310,648

Previous 371,278 16.33%

Holding current value

$23 Million

Previous $22.5 Million 8.77%

% of portfolio

0.04%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $3.48 Million - $4.16 Million	-60,630 Reduced 16.33%	310,648 $20.5 Million
Q2 2024 Aug 13, 2024	BUY	$51.18 - $63.75 $7.92 Million - $9.86 Million	154,663 Added 71.4%	371,278 $22.5 Million
Q1 2024 May 14, 2024	BUY	$56.55 - $66.59 $1.26 Million - $1.48 Million	22,244 Added 11.44%	216,615 $12.3 Million
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $544,706 - $670,336	10,443 Added 5.68%	194,371 $12.2 Million
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $1.18 Million - $1.34 Million	20,389 Added 12.47%	183,928 $10.6 Million
Q2 2023 Aug 14, 2023	BUY	$60.95 - $75.51 $2.66 Million - $3.29 Million	43,580 Added 36.33%	163,539 $10.2 Million
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $609,175 - $746,050	8,674 Added 7.79%	119,959 $8.67 Million
Q4 2022 Feb 13, 2023	BUY	$67.18 - $84.11 $1.84 Million - $2.3 Million	27,341 Added 32.57%	111,285 $8.94 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $413,625 - $517,875	-6,250 Reduced 6.93%	83,944 $5.59 Million
Q2 2022 Aug 12, 2022	SELL	$66.18 - $83.18 $415,279 - $521,954	-6,275 Reduced 6.5%	90,194 $6.85 Million
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $1.63 Million - $1.97 Million	-24,695 Reduced 20.38%	96,469 $7.66 Million
Q4 2021 Feb 11, 2022	BUY	$63.34 - $74.11 $2.66 Million - $3.12 Million	42,055 Added 53.16%	121,164 $8.89 Million
Q3 2021 Nov 12, 2021	BUY	$68.67 - $84.02 $647,832 - $792,644	9,434 Added 13.54%	79,109 $5.44 Million
Q2 2021 Aug 13, 2021	BUY	$79.87 - $87.53 $2.01 Million - $2.2 Million	25,130 Added 56.41%	69,675 $5.86 Million
Q1 2021 May 12, 2021	BUY	$76.02 - $100.5 $1.91 Million - $2.52 Million	25,120 Added 129.32%	44,545 $3.62 Million
Q4 2020 Feb 12, 2021	SELL	$80.74 - $97.7 $674,986 - $816,772	-8,360 Reduced 30.09%	19,425 $1.69 Million
Q3 2020 Nov 12, 2020	SELL	$85.07 - $109.69 $347,510 - $448,083	-4,085 Reduced 12.82%	27,785 $2.49 Million
Q2 2020 Aug 12, 2020	SELL	$74.18 - $108.93 $13,352 - $19,607	-180 Reduced 0.56%	31,870 $3.31 Million
Q1 2020 May 11, 2020	SELL	$63.18 - $85.97 $271,674 - $369,671	-4,300 Reduced 11.83%	32,050 $2.35 Million
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $2.66 Million - $3.48 Million	36,350 New	36,350 $3.17 Million

Others Institutions Holding INCY

# of Institutions

657

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Incyte Corp Transaction History